News & Events
Trasis and Shertech Laboratories, received FDA approval of the [18F]FDG Dual process on AllinOne synthesizers.
Trasis and Shertech Laboratories “hand to hand” work was recently rewarded with approval of a supplemental abbreviated New Drug Application and thus receiving a Marketing Authorization from the U.S. Food and Drug Administration for the [18F]FDG Dual process on AllinOne modules.
#1 Welcoming people on a cosy and peaceful booth while sharing a piece of belgian chocolate
That's true ! As a Belgian company, we shall never forget to bring a little of our heritage with us. It's important for us that people worldwide know Belgium not only as the country where state of the art synthesizers can be found but also as the place to be for specialties as chocolate, beers or french fries.
From the 15th we will be at the BNMS in Birmingham then at the NukMed in Bremen starting on the 18th. And if you don't live in Europe, it might be easier to catch us at the WFNMB in Melbourne or at the CNFMMNM, Mexico.
Jean-Luc Morelle took part of a special case file on the nuclear medicine published in the "Libre Belgique". The special dossier is about the innovative future treatments and Jean-Luc explains how Trasis is involved into it. (P.9)